1-ethyl-4-(2-morpholinoethyl)-3,3-diphenylpyrrolidin-2-one monohydrochloride manufacturers
|
| | 1-ethyl-4-(2-morpholinoethyl)-3,3-diphenylpyrrolidin-2-one monohydrochloride Basic information |
| Product Name: | 1-ethyl-4-(2-morpholinoethyl)-3,3-diphenylpyrrolidin-2-one monohydrochloride | | Synonyms: | 4-[2-(1-Ethyl-5-oxo-4,4-diphenyl-3-pyrolidinyl)ethyl]morpholine·hydrochloride;1-ethyl-4-(2-morpholin-4-ylethyl)-3,3-diphenyl-pyrrolidin-2-one hydrochloride;1-ethyl-4-(2-morpholin-4-ylethyl)-3,3-diphenylpyrrolidin-2-one hydrochloride;1-ethyl-4-(2-morpholinoethyl)-3,3-diphenyl-2-pyrrolidone hydrochloride;1-ethyl-4-(2-morpholinoethyl)-3,3-diphenylpyrrolidin-2-one monohydrochloride;DOXAPRAMHYDROCHLORIDE,ANHYDROUS;1-Ethyl-4-(2-morpholinoethyl)-3,3-diphenyl-2-pyrrolidinone hydrochloride;2-Pyrrolidinone, 1-ethyl-4-(2-morpholinoethyl)-3,3-diphenyl-, hydrochloride (7CI) | | CAS: | 113-07-5 | | MF: | C24H31ClN2O2 | | MW: | 414.96814 | | EINECS: | 204-022-3 | | Product Categories: | | | Mol File: | 113-07-5.mol |  |
| | 1-ethyl-4-(2-morpholinoethyl)-3,3-diphenylpyrrolidin-2-one monohydrochloride Chemical Properties |
| storage temp. | Sealed in dry,Room Temperature | | InChI | InChI=1S/C24H30N2O2.ClH/c1-2-26-19-22(13-14-25-15-17-28-18-16-25)24(23(26)27,20-9-5-3-6-10-20)21-11-7-4-8-12-21;/h3-12,22H,2,13-19H2,1H3;1H | | InChIKey | MBGXILHMHYLZJT-UHFFFAOYSA-N | | SMILES | C1(C(=O)N(CC)CC1CCN1CCOCC1)(C1C=CC=CC=1)C1C=CC=CC=1.Cl |
| RIDADR | 3249 | | HazardClass | 6.1(b) | | PackingGroup | III |
| | 1-ethyl-4-(2-morpholinoethyl)-3,3-diphenylpyrrolidin-2-one monohydrochloride Usage And Synthesis |
| Uses | Doxapram Hydrochloride is a respiratory stimulant that has an inhibitory effect on myocardial IK1 potassium channel. | | Uses | Anaesthetics | | Definition | ChEBI: The hydrochloride salt of doxapram. A central and respiratory stimulant with a brief duration of action, both doxapram hydrochloride and its hydrate are used as a temporary treatment of acute respiratory failure, particularly when superimposed on chronic o
structive pulmonary disease, and of postoperative respiratory depression. It has also been used for treatment of postoperative shivering. |
| | 1-ethyl-4-(2-morpholinoethyl)-3,3-diphenylpyrrolidin-2-one monohydrochloride Preparation Products And Raw materials |
|